UNSPSC 51293702: Nomifensine

This classification denotes an antidepressant agent with the molecular formula C16H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1LGS5JRP31, chemically known as 1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquino* but generally known as nomifensine, which bears US NIH Compound Identifier 4528. European Medicines Agency schedules Nomifensine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09347MIG.

UNSPSC 51293702 Nomifensine, a Commodity code, does not align with the state and local procurement activity currently tagged under it. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits Naloxone and Safe Drug Deactivation Systems, products unrelated to nomifensine, an antidepressant pharmaceutical with limited use in modern clinical practice. The mismatch suggests either a cataloging error in the county's tagging system or a temporary misalignment between code assignment and actual procurement need. State and local procurement offices rarely issue solicitations for nomifensine specifically, and the Seminole County opportunity represents a community health initiative focused on opioid overdose response and drug disposal, not antidepressant therapy.

Seminole County's procurement calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify compliance, drug-free workplace certification, and potential FEMA funding with associated federal environmental compliance requirements. The response deadline was July 26, 2023, at 2:00 pm. Beyond this single opportunity, the code shows no recent relevant state and local activity.